Predictors of success and failure in achieving glycemic control targets in patients with type 2 diabetes on basal insulin: review of the real-world evidence studies

Basal insulin (BI) is the main therapeutic option for patients with type 2 diabetes (T2D) who have not reached glycemic targets on oral antidiabetic drugs and/or glucagon-like peptide-1 receptor agonists. The results of epidemiological studies indicate that the majority of patients with T2D do not a...

Full description

Saved in:
Bibliographic Details
Main Author: V. V. Klimontov
Format: Article
Language:English
Published: Endocrinology Research Centre 2023-01-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/12950
Tags: Add Tag
No Tags, Be the first to tag this record!